Error message

There was an error processing your request.

Multiple insider buying at Cannvas MedTech (MTEC)

Multiple insider buying at Cannvas MedTech (:MTEC)

Updated Tuesday Jan 22, 2019 02:21 AM EDT
Steve Loutskou, a Senior Officer, Director and 10% Holder, acquired 500,000 Common Shares on an indirect ownership basis for registered holder FourOneSix Inc. at a price of $0.300 through a prospectus or prospectus exempt offering on January 21st, 2019. This represents a $150,000 investment into the company's shares and an account share holdings change of 7.6%.

Shawn Moniz, a Senior Officer, Director and 10% Holder, acquired 500,000 Common Shares on an indirect ownership basis for registered holder Fusionworx Investment Group Inc. at a price of $0.300 through a prospectus or prospectus exempt offering on January 21st, 2019. This represents a $150,000 investment into the company's shares and an account share holdings change of 7.5%.

Miroslav Beganovic, a Senior Officer, acquired 16,667 Common Shares on a direct ownership basis at a price of $0.300 through a prospectus or prospectus exempt offering on January 21st, 2019. This represents a $5,000 investment into the company's shares and an account share holdings change of 8.3%.

Cannvas MedTech is in the Software Sub Industry Group under the Technology Sector.

Cannvas MedTech Inc is a Canada-based company engaged in enterprise development sector. The Company is creator of online health sciences educational platform where patients can take an active role in defining the path of control of their health and wellness through the use of cannabis. It is a solution for the global cannabis community offering interactive tools and physician-backed content. Through subsidiaries Cannvas Creative, Cannvas Data and Cannvas Connect, the Company features tools, such as educational learning modules in its Cannvas University, an interactive Cannvas Strain Matcher that educates audiences with specific ailments and Cannvas Culinary, for those wishing to learn about the culinary approach to treatments.


Top